Abstract:Dystrophia myotonica type 1 (DM1) is an autosomal dominant multisystem disorder. The pathogenesis of central nervous system (CNS) involvement is poorly understood. Disease-specific induced pluripotent stem cell (iPSC) lines would provide an alternative model. In this study, we generated two DM1 lines and a normal iPSC line from dermal fibroblasts by retroviral transduction of Yamanaka's four factors (hOct4, hSox2, hKlf4, and hc-Myc). Both DM1 and control iPSC clones showed typical human embryonic stem cell (hESC) growth patterns with a high nuclear-to-cytoplasm ratio. The iPSC colonies maintained the same growth pattern through subsequent passages. All iPSC lines expressed stem cell markers and differentiated into cells derived from three embryonic germ layers. All iPSC lines underwent normal neural differentiation. Intranuclear RNA foci, a hallmark of DM1, were detected in DM1 iPSCs, neural stem cells (NSCs), and terminally differentiated neurons and astrocytes. In conclusion, we have successfully established disease-specific human DM1 iPSC lines, NSCs, and neuronal lineages with pathognomonic intranuclear RNA foci, which offer an unlimited cell resource for CNS mechanistic studies and a translational platform for therapeutic development.

Generation of an Induced Pluripotent Stem Cell Line (FDCHI007-A) Derived from a Patient with Developmental and Epileptic Encephalopathy Type 31 Carrying Heterozygous C.545c > A Mutation in DNM1 Gene

Generation of an induced pluripotent stem cell line (ZJUi013-A) from a Familial cortical myoclonic tremor with epilepsy type 1 patient carrying (TTTCA)n insertion in the SAMD12 gene

Generation of a Human Ipsc Line (Zjshdpi001-A) from Peripheral Blood Mononuclear Cells of a Patient with Developmental Epileptic Encephalopathy-47 Carrying FGF12 Gene Mutation (c.334g > A)

Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Generation of a Human Ipsc Line CIPi003-A from a Patient with Focal Epilepsy Harboring a Heterozygous Mutation in DEPDC5 Gene.

Generation of Five Induced Pluripotent Stem Cell Lines with DMD/c.497G > T Mutation from Renal Epithelial Cells of a Duchenne Muscular Dystrophy Patient and a Recessive Carrier Parent

Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.881C > T; p.Ala294Val (NUIGi059-A, NUIGi059-B, NUIGi059-C) and 3 healthy controls (NUIGi060-A, NUIGi060-B, NUIGi060-C)

Establishment Of An Induced Pluripotent Stem Cell Line (Zjshi001-A) From A Patient With Epileptic Encephalopathy Carrying Kcnb1 Glu330asp Mutation

An iPSC line (FINi003-A) from a male with late-onset developmental and epileptic encephalopathy caused by a heterozygous p.E1211K variant in the SCN2A gene encoding the voltage-gated sodium channel Na v 1.2

Generation of a human induced pluripotent stem cell line (FDCHi012-A) from a patient with DYRK1A-related intellectual disability syndrome carrying DYRK1A mutation (c.1024G > T)

An induced pluripotent stem cell line (EHTJUi004-A) generated from a neonate with c.4683_4684delCT:p.Leu1563fs mutation in the gene <i>DSP</i> causing Familial Arrhythmogenic Right Ventricular Dysplasia (ARVD)

Generation of a Human Induced Pluripotent Stem Cell Line (Sbwchi001-A) from a Patient with NEDSDV Carrying a Pathogenic Mutation in CTNNB1 Gene.

Induced pluripotent stem cells (SHCDNi006-A cells) isolated from the peripheral blood mononuclear cells of a five-month-old Chinese girl with the heterozygous missense mutation (c.2800 G>A) in the KCNT1 gene

Generation of an induced pluripotent stem cell line GWCMCi006-A from a patient with autosomal dominant neurodevelopmental disorder with or without hyperkinetic movements and seizures harboring GRIN1 c.389A > G mutation

Generation of a Human Induced Pluripotent Stem Cell Line (Cipi002-A) from an Early Infantile Epileptic Encephalopathy Patient with a Heterozygous Mutation in SCN8A

Generation of an Induced Pluripotent Stem Cell Line from a Patient with Global Development Delay Carrying DYRK1A Mutation (c.1730t>a) and a Gene Correction Isogenic Ipsc Line.

Derivation of an induced pluripotent stem cell line (FDCHi014-A) from PBMCs of a seven-year-old patient with a truncating NOVA2 variant (c.625del)

An induced pluripotent stem cell line (EHTJUi002-A) derived from a neonate with c.678G > A mutation in the gene <i>FZD4</i> causing exudative vitreoretinopathy

Generation of Induced Pluripotent Stem Cell Line, ZJUCHi002-A, from Charcot-Marie-Tooth Disease Type 2A (CMT2A) Patient with a Mutation of C.752c>t in MFN2

An Induced Pluripotent Stem Cell Line (Ehtjui003-A) Generated From A Neonate With C.1377delc Mutation In The Gene Mybpc3 Causing Hypertrophic Cardiomyopathy

Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi055-A from a patient with NEDSDV carrying a heterozygote mutation in the CTNNB1 gene